SCHEMBL12700258

SCHEMBL12700258

N#Cc1ccc(NC(=O)c2cccc(C(=O)O)c2)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.69
KMT2A Q03164 4/20 0.69
PKM P14618 1/20 0.61
L3MBTL1 Q9Y468 1/20 0.61
F2 P00734 1/20 0.59
PLG P00747 1/20 0.59
PLAU P00749 1/20 0.59
KLKB1 P03952 1/20 0.59
PRSS1 P07477 1/20 0.59
LMNA P02545 1/20 0.57
POLB P06746 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
TAS1R3 Q7RTX0 1/20 0.56
TAS1R1 Q7RTX1 1/20 0.56
TAS1R2 Q8TE23 1/20 0.56
HPSE Q9Y251 1/20 0.56
ROCK2 O75116 1/20 0.56
NPC1 O15118 1/20 0.56
RAB9A P51151 1/20 0.56
TP53 P04637 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9587298 0.88 MEN1 (0.65) MEN1KMT2AF2PLGPLAU
SCHEMBL3610083 0.87 HPSE (0.67) MEN1KMT2APKML3MBTL1F2
SCHEMBL1344198 0.85 F2 (0.72) MEN1KMT2AF2PLGPLAU
Hydrochloric Acid SCHEMBL2105154 0.85 HPSE (0.65) MEN1KMT2APKML3MBTL1F2
SCHEMBL31311100 0.84 MLYCD (0.68) MEN1KMT2AF2PLGPLAU
SCHEMBL20764458 0.84 MLYCD (0.68) MEN1KMT2AF2PLGPLAU
SCHEMBL2058359 0.84 KMT2A (0.96) MEN1KMT2APKML3MBTL1POLB
SCHEMBL9057146 0.84 NPC1 (0.65) MEN1KMT2AL3MBTL1LMNAPOLB
SCHEMBL19662802 0.84 TP53 (0.68) MEN1KMT2AL3MBTL1LMNAPOLB
Hydrochloric Acid SCHEMBL2104599 0.82 HTT (0.60) MEN1KMT2APKML3MBTL1F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10166237-B2 Compounds and methods for inducing chondrogenesis THE SCRIPPS RESEARCH INSTITUTE (US) 2019-01-01 US disclosed
US-20170112843-A1 COMPOUNDS AND METHODS FOR INDUCING CHONDROGENESIS THE SCRIPPS RESEARCH INSTITUTE 2017-04-27 US disclosed
US-9464065-B2 Compounds and methods for inducing chondrogenesis THE SCRIPPS RESEARCH INSTITUTE (US) 2016-10-11 US disclosed
WO-2012129562-A2 COMPOUNDS AND METHODS FOR INDUCING CHONDROGENESIS THE SCRIPPS RESEARCH INSTITUTE (US) 2012-09-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10166237-B2 Compounds and methods for inducing chondrogenesis COL2A1, BMP4, BMP2 MEN1 4660/4885KMT2A 3000/4885PKM 4402/4885
US-20170112843-A1 COMPOUNDS AND METHODS FOR INDUCING CHONDROGENESIS COL2A1, BMP4, BMP2 MEN1 4660/4885KMT2A 3000/4885PKM 4402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.